Skip to main content
. 2012 May 18;7(5):e37136. doi: 10.1371/journal.pone.0037136

Figure 4. Evaluation of the CWTrAP system using somatostatin peptide for the human SSTR5 receptor.

Figure 4

(A) SSTR5 signaling assays of the cyclic somatostatin peptide displaying yeast strain and control strains. (B) SSTR5 signaling assays of non-target peptide displaying yeast strains. IMFD-70 was used as the host strain. The transformants used in these experiments are listed in Table S3. S-14 indicates 14 aa of somatostatin cyclic peptide, α-factor indicates 13 aa of yeast pheromone peptide, AII indicates 8 aa of angiotensin II peptide, and ET1 indicates 21 aa of endothelin-1 peptide.